Complete Filing Data
Nano-X Imaging Ltd. reported Stockholders Equity of $189.12 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Nano-X Imaging Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$53.5M | -$60.8M | -$113.2M | -$61.8M | -$43.8M | -$22.6M | -$1.9M |
| Selling And Marketing Expense | $3.4M | $4.2M | $4.4M | $7.0M | $12.4M | $1.6M | $209.0K |
| Research And Development Expense | $20.2M | $26.0M | $26.5M | $17.1M | $9.2M | $2.7M | $672.0K |
| Operating Income Loss | -$56.7M | -$62.6M | -$117.7M | -$61.6M | -$43.9M | -$22.6M | -$1.9M |
| Operating Expenses | $46.1M | $56.0M | $110.8M | $60.0M | $43.9M | $22.6M | $1.9M |
| General And Administrative Expense | $22.5M | $24.3M | $41.3M | $34.7M | $22.3M | $18.3M | $1.0M |
| Interest Income Expense Nonoperating Net | $2.9M | $1.7M | $789.0K | -$288.0K | $108.0K | $8.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$53.9M | -$61.1M | -$116.9M | -$61.8M | -$43.8M | -$22.6M | |
| Comprehensive Income Net Of Tax | -$53.2M | -$59.1M | -$114.6M | -$62.4M | -$43.8M | -$22.6M | |
| Revenues | $11.3M | $9.9M | $8.6M | $1.3M | |||
| Other Comprehensive Income Loss Net Of Tax | $304.0K | $1.7M | -$1.4M | -$607.0K | |||
| Income Taxes Paid Net | $53.0K | $3.0K | $147.0K | $7.0K | $8.0K | ||
| Income Tax Expense Benefit | -$358.0K | -$339.0K | -$3.7M | -$48.0K | |||
| Gross Profit | -$10.6M | -$6.6M | -$6.9M | -$1.5M | |||
| Deferred Income Tax Expense Benefit | -$377.0K | -$377.0K | -$3.7M | -$116.0K | |||
| Cost Of Revenue | $21.9M | $16.5M | $15.5M | $2.8M | |||
| Amortization Of Intangible Assets | $10.6M | $10.6M | $10.6M | $1.8M | |||
| Deferred Income Tax Liabilities Net | $2.6M | $3.0M | $3.3M | $7.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $189.1M | $195.5M | $216.7M | $292.1M | $230.7M | -$8.8M | -$6.4M | -$8.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$17.1M | $17.8M | -$28.2M | -$147.0M | $205.6M | $8.2M | -$60.0K | |
| Assets | $210.0M | $218.6M | $253.9M | $363.2M | $236.1M | $11.9M | ||
| Retained Earnings Accumulated Deficit | -$373.7M | -$320.2M | -$259.5M | -$146.2M | -$84.4M | -$40.6M | ||
| Property Plant And Equipment Net | $45.4M | $42.3M | $43.5M | $37.4M | $14.0M | $228.0K | ||
| Other Assets Noncurrent | $1.8M | $2.2M | $2.9M | $1.1M | $661.0K | $139.0K | ||
| Operating Lease Right Of Use Asset | $3.8M | $4.6M | $1.2M | $1.7M | $1.4M | $526.0K | ||
| Operating Lease Liability Noncurrent | $3.6M | $4.0M | $398.0K | $950.0K | $923.0K | $386.0K | ||
| Operating Lease Liability Current | $745.0K | $861.0K | $740.0K | $881.0K | $519.0K | $140.0K | ||
| Liabilities Noncurrent | $6.9M | $7.6M | $12.2M | $18.3M | $923.0K | $386.0K | ||
| Liabilities Current | $14.0M | $15.5M | $25.1M | $52.8M | $4.5M | $20.3M | ||
| Liabilities And Stockholders Equity | $210.0M | $218.6M | $253.9M | $363.2M | $236.1M | $11.9M | ||
| Liabilities | $20.9M | $23.1M | $37.3M | $71.0M | $5.4M | $20.6M | ||
| Common Stock Value | $181.0K | $165.0K | $158.0K | $149.0K | $131.0K | $75.0K | ||
| Cash And Cash Equivalents At Carrying Value | $39.3M | $56.4M | $38.5M | $66.6M | $213.5M | $8.1M | ||
| Assets Noncurrent | $131.3M | $130.0M | $171.5M | $268.3M | $16.4M | $2.2M | ||
| Assets Current | $78.7M | $88.6M | $82.5M | $94.9M | $219.8M | $9.6M | ||
| Accrued Liabilities Current | $4.0M | $3.9M | $12.2M | $3.6M | $1.9M | $1.8M | ||
| Accounts Payable Current | $2.2M | $3.3M | $3.6M | $3.1M | $435.0K | $475.0K | ||
| Increase Decrease Operating Lease | $352.0K | -$125.0K | $23.0K | $83.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $56.4M | $38.5M | $66.8M | $213.8M | $8.2M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations | $39.3M | $56.4M | $38.5M | $66.8M | $213.8M | |||
| Recognition Of Operating Lease Rightofuse Asset Against Operating Lease Liabilities | $320.0K | $194.0K | $1.1M | $548.0K | ||||
| Other Liabilities Current | $3.8M | $3.4M | $4.0M | $2.3M | $1.6M | |||
| Other Assets Current | $1.3M | $1.1M | $1.4M | $2.0M | $1.5M | |||
| Marketable Securities Unrealized Gain Loss | $306.0K | $1.5M | -$1.4M | -$607.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $66.8M | $213.8M | $8.2M | $5.0K | $65.0K | |||
| Other Liabilities Noncurrent | $695.0K | $612.0K | $483.0K | $233.0K | ||||
| Marketable Securities Current | $18.4M | $26.0M | $39.2M | $22.1M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.0K | -$305.0K | -$2.0M | -$607.0K | ||||
| Accounts And Other Receivables Net Current | $1.8M | $1.5M | $977.0K | $1.1M | ||||
| Restricted Cash | $66.0K | $127.0K | $316.0K | $145.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $7.3M | $6.8M | $18.6M | $18.8M | $24.8M | $16.2M | $115.0K |
| Payments To Acquire Property Plant And Equipment | $2.8M | $3.3M | $7.2M | $23.2M | $13.9M | $125.0K | $73.0K |
| Net Cash Provided By Used In Operating Activities | -$36.6M | -$44.8M | -$43.4M | -$38.1M | -$21.6M | -$5.5M | -$3.7M |
| Net Cash Provided By Used In Investing Activities | -$20.1M | $35.4M | $14.6M | -$116.3M | -$13.9M | -$125.0K | -$73.0K |
| Net Cash Provided By Used In Financing Activities | $39.5M | $27.3M | $804.0K | $7.4M | $241.0M | $13.9M | $3.7M |
| Increase Decrease In Accounts Payable Trade | -$1.3M | -$153.0K | $469.0K | $1.7M | -$103.0K | $393.0K | -$134.0K |
| Proceeds From Warrant Exercises | $370.0K | $267.0K | $630.0K | $162.0K | |||
| Proceeds From Stock Options Exercised | $1.7M | $903.0K | $579.0K | $3.3M | |||
| Increase Decrease In Receivables | $321.0K | $507.0K | -$74.0K | $40.0K | |||
| Increase Decrease In Prepaid Expenses Other | -$1.2M | -$1.7M | $4.5M | $1.6M | -$66.0K | ||
| Increase Decrease In Other Noncurrent Assets | -$218.0K | $251.0K | $800.0K | $374.0K | $522.0K | ||
| Employee Benefits And Share Based Compensation | $18.6M | $18.7M | $24.8M | $16.2M | $115.0K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $72.0K | -$60.0K | -$268.0K | -$10.0K | $122.0K | ||
| Proceeds From Sale Of Held To Maturity Securities | $41.2M | $38.3M | $31.2M | $11.0M | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $10.4M | -$719.0K | $2.4M | $970.0K | |||
| Proceeds From Issuance Of Ordinary Shares And Warrants Net Of Issuance Costs | 27.1M | 71.0M | 14.0M | 3.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.91 | -$1.08 | -$2.17 | -$1.28 | -$1.23 | -$0.90 | -$0.09 |
| Weighted Average Number Of Shares Outstanding Basic | 58.7M | 56.4M | 52.2M | 48.2K | 35.7K | 25.2K | |
| Earnings Per Share Basic | $-0.91 | $-1.08 | $-2.17 | $-1.28 | $-1.23 | $-0.90 | |
| Common Stock Shares Issued | 63.8M | 57.8M | 55.1M | 51.8M | 46.1M | 27.2M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 40.0M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Common Stock Shares Outstanding | 57.8M | 55.1M | 51.8M | 46.1M | 27.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Depreciation | $1.1M | $1.2M | $905.0K | $524.0K | $208.0K | $53.0K | $35.0K |
| Unrealized Loss From Availableforsale Securities | $304.0K | $1.7M | -$1.4M | -$607.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $1.7M | $903.0K | $579.0K | $3.3M | |||
| Prepaid Expense Current | $827.0K | $1.3M | $2.4M | $3.1M | $4.8M | ||
| Dividends And Interest Paid | $140.0K | $149.0K | $90.0K | $13.0K | |||
| Additional Paid In Capital | $515.9M | $478.0M | $438.8M | $315.0M | $31.7M | ||
| Stock Issued During Period Value Other | $27.1M | $169.2M | $137.0K |
Most recent annual filing with the SEC: April 9, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.